Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03586869
Title QUILT-3.080: NANT Pancreatic Cancer Vaccine
Recruitment Unknown status
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors NantKwest, Inc.
Indications

pancreatic adenocarcinoma

Therapies

Aldoxorubicin + ALT-803 + Avelumab + Bevacizumab + Capecitabine + Cyclophosphamide + ETBX-011 + ETBX-021 + ETBX-051 + ETBX-061 + Fluorouracil + Gemcitabine + GI-4000 + GI-6207 + GI-6301 + haNK cells + Leucovorin + Nab-paclitaxel + Oxaliplatin

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.